Skip to main content

Table 3 Clinical–epidemiological characteristics of the population with CKD according to the vital status

From: Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as risk factors for mortality in Peruvian adults with chronic kidney disease

Characteristics Vital status p Value
Dead (n = 60) Alive (n = 283)
Age (years)* 81.9 (10.1) 77.5 (12.2)  < 0.01
Sex** 0.01
Female 14 (11.0) 113 (89.0)  
Male 46 (21.3) 170 (78.7)  
Hypertension** 0.52
Yes 41 (18.5) 181 (81.5)  
No 19 (15.7) 102 (84.3)  
Diabetes** 0.06
Yes 24 (23.3) 79 (76.7)  
No 36 (15.0) 204 (85.0)  
CKD stage**  < 0.01
1,2 2 (9.1) 20 (90.9)  
3a–3b 51 (16.4) 260 (83.6)  
4–5 7 (70.0) 3 (30.0)  
Laboratory profile
Serum creatinine (mg/dL)* 1.6 (0.9) 1.4 (0.3)  < 0.01
eGFR (ml/min/1.73 m2)* 45.0 (11.5) 47.9 (10.2) 0.05
Glucose (mg/dL)*** 91.5 (84–104) 90 (82–103) 0.55
Total protein (g/dL)* 7.2 (1.0) 7.3 (0.6) 0.27
Albumin (g/dL)* 4.0 (0.4) 4.2 (0.4)  < 0.01
AST (U/L)*** 23 (19–27) 23 (19–28) 0.70
ALT (U/L)*** 17.5 (14–23) 18.0 (13–24) 0.96
Total bilirubin (mg/dL)*** 0.6 (0.4–0.8) 0.6 (0.5–0.8) 0.63
Alkaline phosphatase (U/L)*** 101 (80–132) 101 (82–127) 0.71
Globulin (g/dL)* 3.2 (0.6) 3.1 (0.8) 0.66
Hemoglobin (g/dL)* 11.7 (1.9) 12.3 (1.6) 0.03
Platelets (K/uL)* 225 (107.8) 240 (76.1) 0.20
Neutrophils (K/uL)* 4.1 (1.6) 3.9 (1.5) 0.49
  1. eGFR estimated glomerular filtration rate, CKD chronic kidney disease, AST aspartate aminotransferase, ALT alanine aminotransferase
  2. *Mean (standard deviation)
  3. **Frequency (percent)
  4. ***Median (p25–p75)